TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

Clinical trial NCT04323657 · COMPLETED

Trial details

NCT number: NCT04323657
Sponsor: TCR2 Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma Acute Lymphoblastic Leukemia Diffuse Large B Cell Lymphoma Primary Mediastinal Large B Cell Lymphoma Mantle Cell Lymphoma Follicular Lymphoma

Start date: 2020-03-27
Primary completion: 2023-02-24
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.